David M. Ryckman
Profile
Dr. David M.
Ryckman is VP-Chemistry & Pharmaceutical Operations at Senhwa Biosciences, Inc.
Dr. Ryckman was previously employed as a Principal by GlaxoSmithKline Plc, a Principal by Gensia Pharmaceuticals, Inc., a Principal by Honeywell Corp., a Principal by Novartis, Inc., and VP-Manufacturing & Pharmaceutical Operations by Cylene Pharmaceuticals, Inc.
He received his undergraduate degree from the University of California, Los Angeles, a graduate degree from California State University-Northridge, and a doctorate degree from the University of California, Los Angeles.
Former positions of David M. Ryckman
| Companies | Position | End |
|---|---|---|
| Honeywell Corp. | Corporate Officer/Principal | - |
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Corporate Officer/Principal | - |
| GSK PLC | Corporate Officer/Principal | - |
| SENHWA BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Gensia Pharmaceuticals, Inc.
 Gensia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gensia Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products for cardiovascular diseases. The company is based in San Diego, CA and has subsidiaries in the United States. The company was founded by Robert L. Engler, Paul K. Laikind. | Corporate Officer/Principal | - |
Training of David M. Ryckman
| University of California, Los Angeles | Doctorate Degree |
| California State University-Northridge | Graduate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 2 |
|---|---|
| SENHWA BIOSCIENCES, INC. | Commercial Services |
| GSK PLC | Health Technology |
| Private companies | 4 |
|---|---|
Cylene Pharmaceuticals, Inc.
 Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Health Technology |
Gensia Pharmaceuticals, Inc.
Gensia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gensia Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products for cardiovascular diseases. The company is based in San Diego, CA and has subsidiaries in the United States. The company was founded by Robert L. Engler, Paul K. Laikind. | Health Technology |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Health Technology |
| Honeywell Corp. |
- Stock Market
- Insiders
- David M. Ryckman
